Exane Derivatives
- SEC CIK
- 0001623883
- Latest filing
- Jul 12, 2022
KRTX holding history
Karuna Therapeutics, Inc. in every 13F filed by Exane Derivatives, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRTX overviewAll 13F holders of KRTXFull Q2 2022 holdings
- Shares (Q2 2022)
- 740
- Value
- $93.6K
- % of portfolio
- 0.1%
- Quarters held
- 3
- Since Q4 2021